BlueRock Therapeutics
Bayer opens new $250M facility in Berkeley to launch its cell therapy products
Anika Sharma
In a significant move to address the challenges of scaling up the production of cell therapies, Bayer, through its subsidiary ...
In a significant move to address the challenges of scaling up the production of cell therapies, Bayer, through its subsidiary ...